Drug Prices Are Not Justified By Industry’s Research And Development Spending
Most industry spending is not on research and development which has patients paying at both ends of drug production. Government action is needed to encourage research and development focused on public health priorities. High drug prices are not justified by the industry’s spending on research and development (R&D), argue experts in The BMJ today. Aris …